This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Bar-Ilan University. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: David Smadja: Innovator in Eye Condition Correction
Introduction
David Smadja is a notable inventor based in Tel Aviv, Israel. He has made significant contributions to the field of ophthalmology through his innovative patent. His work focuses on developing systems and materials that aid in the correction of eye conditions.
Latest Patents
David Smadja holds a patent for a "System, method and material composition for use in correction of eye conditions." This invention includes a processing utility and an etching utility designed to correct vision impairments. The processing utility features a correction pattern module that generates a two-dimensional pattern based on user input. This pattern is then etched onto the cornea's surface using the etching utility. The material composition consists of an aqueous solution containing nanoparticles, specifically maghemite nanoparticles wrapped in biocompatible protein chains. These nanoparticles can be used as eye drops, allowing them to occupy the etched regions on the cornea, thus maintaining the correction of the eye condition. David Smadja has 1 patent to his name.
Career Highlights
David Smadja is affiliated with Bar-Ilan University, where he continues to advance his research and innovations in eye care. His work has the potential to significantly improve the quality of life for individuals suffering from various eye conditions.
Collaborations
David has collaborated with esteemed colleagues such as Zeev Zalevsky and Jean Paul Lellouche, contributing to the advancement of technology in the field of vision correction.
Conclusion
David Smadja's innovative approach to correcting eye conditions showcases his dedication to improving healthcare through technology. His contributions are paving the way for future advancements in ophthalmology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
